SCHEMBL30476338

SCHEMBL30476338

CC(C)(C)OC(=O)N1CCN(Cc2ccc(F)cc2Br)CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.54
▸ MGLL Q99685 4/20 0.50
▸ KDM4E B2RXH2 4/20 0.48
▸ IDO1 P14902 1/20 0.47
▸ TDO2 P48775 1/20 0.47
▸ IDO2 Q6ZQW0 1/20 0.47
▸ VEGFA P15692 1/20 0.47
▸ EGLN1 Q9GZT9 1/20 0.47
▸ GPR119 Q8TDV5 1/20 0.46
▸ PLA2G7 Q13093 1/20 0.45
▸ ABHD6 Q9BV23 1/20 0.45
▸ POLB P06746 1/20 0.44
▸ GPR183 P32249 1/20 0.44
▸ PLK1 P53350 1/20 0.44
▸ CHRM2 P08172 1/20 0.44
▸ CHRM4 P08173 1/20 0.44
▸ CHRM1 P11229 1/20 0.44
▸ CHRM3 P20309 1/20 0.44
▸ MMP1 P03956 1/20 0.44
▸ MMP9 P14780 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14456695 1.00 ALDH1A1 (0.54) ALDH1A1MGLLKDM4EIDO1TDO2
SCHEMBL15058679 0.91 ALDH1A1 (0.51) ALDH1A1MGLLKDM4EIDO1TDO2
SCHEMBL2843836 0.88 ALDH1A1 (0.69) ALDH1A1MGLLKDM4EIDO1TDO2
SCHEMBL30476377 0.87 ALDH1A1 (0.58) ALDH1A1MGLLKDM4EIDO1TDO2
SCHEMBL20818719 0.87 ALDH1A1 (0.58) ALDH1A1MGLLKDM4EIDO1TDO2
SCHEMBL19386351 0.87 MGLL (0.48) ALDH1A1MGLLKDM4EVEGFAEGLN1
SCHEMBL18064897 0.86 MGLL (0.53) MGLLPLA2G7ABHD6
SCHEMBL15093856 0.86 VEGFA (0.57) ALDH1A1MGLLKDM4EVEGFAEGLN1
SCHEMBL4277006 0.85 LMNA (0.49) ALDH1A1MGLLKDM4EVEGFAEGLN1
SCHEMBL2234786 0.83 ALDH1A1 (0.54) ALDH1A1MGLLKDM4EVEGFAEGLN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12435078-B2 Pyridazinones and methods of use thereof GFB (ABC), LLC (US) 2025-10-07 — — US disclosed
US-20230203028-A1 PYRIDAZINONES AND METHODS OF USE THEREOF GFB (ABC), LLC 2023-06-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230203028-A1 PYRIDAZINONES AND METHODS OF USE THEREOF PDXK, ATP6V1B1, REN ALDH1A1 649/4885MGLL 4378/4885KDM4E 3899/4885
US-12435078-B2 Pyridazinones and methods of use thereof PDXK, ATP6V1B1, REN ALDH1A1 649/4885MGLL 4378/4885KDM4E 3899/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback